Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Up 1,922.2% in December

Carl Zeiss Meditec AG (OTCMKTS:CZMWYGet Free Report) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 364 shares, an increase of 1,922.2% from the November 30th total of 18 shares. Based on an average trading volume of 3,454 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 3,454 shares, the days-to-cover ratio is currently 0.1 days.

Analysts Set New Price Targets

Separately, Barclays assumed coverage on shares of Carl Zeiss Meditec in a research note on Tuesday, September 9th. They issued an “overweight” rating for the company. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Check Out Our Latest Analysis on CZMWY

Carl Zeiss Meditec Trading Down 0.0%

Shares of CZMWY traded down $0.01 during trading hours on Wednesday, hitting $47.32. 407 shares of the stock traded hands, compared to its average volume of 3,769. Carl Zeiss Meditec has a 1-year low of $45.96 and a 1-year high of $76.28. The business has a fifty day moving average of $50.32 and a 200-day moving average of $54.23.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.

Featured Stories

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.